Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children.
D000293:Adolescent; D000339:Affect / Q000187:drug effects; D000374:Aggression / Q000187:drug effects; D001321:Autistic Disorder / Q000188:drug therapy; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D002675:Child, Preschool; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D012561:Schizophrenia, Childhood / Q000188:drug therapy*; D013060:Speech / Q000187:drug effects
D008094:Lithium; D002746:Chlorpromazine